STAAR Surgical Company

NasdaqGM:STAA Stock Report

Market Cap: US$1.6b

STAAR Surgical Management

Management criteria checks 0/4

STAAR Surgical's CEO is Tom Frinzi, appointed in Jan 2023, has a tenure of 1.67 years. total yearly compensation is $10.22M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 0.046% of the company’s shares, worth $734.82K. The average tenure of the management team and the board of directors is 1.7 years and 3 years respectively.

Key information

Tom Frinzi

Chief executive officer

US$10.2m

Total compensation

CEO salary percentage7.7%
CEO tenure1.7yrs
CEO ownership0.05%
Management average tenure1.7yrs
Board average tenure3yrs

Recent management updates

Recent updates

STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize

Sep 05

Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 10
Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates

STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear

Aug 05
STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear

The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing

Jul 12
The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

May 27
Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher

Apr 26
Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher

STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge

Apr 05

STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue

Mar 25
STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue

STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade

Mar 13

STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump

Mar 07
STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

Jan 31
Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For

Jan 05
With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For

Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)

Nov 30
Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)

Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?

Nov 12
Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?

Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?

Oct 25
Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?

Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes

Aug 24
Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes

Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?

Jul 02
Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?

Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?

Jun 17
Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

May 13
Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

Mar 26
A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital

Mar 12
STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital

Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?

Feb 13
Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

Jan 28
Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

Dec 15
Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising

Dec 01
The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising

What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?

Oct 26
What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?

Keep Adding To STAAR Surgical Longs, Buy Thesis Remains

Sep 20

Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?

Sep 05
Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?

STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate

Aug 21
STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate

STAAR Surgical rises 15% on Q2 result beat

Aug 11

CEO Compensation Analysis

How has Tom Frinzi's remuneration changed compared to STAAR Surgical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 28 2024n/an/a

US$17m

Mar 29 2024n/an/a

US$15m

Dec 29 2023US$10mUS$788k

US$21m

Sep 29 2023n/an/a

US$19m

Jun 30 2023n/an/a

US$26m

Mar 31 2023n/an/a

US$33m

Dec 30 2022US$274kn/a

US$40m

Sep 30 2022n/an/a

US$38m

Jul 01 2022n/an/a

US$34m

Apr 01 2022n/an/a

US$29m

Dec 31 2021US$250kn/a

US$28m

Oct 01 2021n/an/a

US$23m

Jul 02 2021n/an/a

US$21m

Apr 02 2021n/an/a

US$11m

Jan 01 2021US$182kn/a

US$6m

Compensation vs Market: Tom's total compensation ($USD10.22M) is above average for companies of similar size in the US market ($USD5.53M).

Compensation vs Earnings: Tom's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


CEO

Tom Frinzi (68 yo)

1.7yrs

Tenure

US$10,220,581

Compensation

Mr. Thomas G. Frinzi, also known as Tom, serves as Executive Chairman of the Board at ViaLase, Inc. since November 2022 and joined the company in November 2022. He serves as Executive Chair at Aurion Biote...


Leadership Team

NamePositionTenureCompensationOwnership
Thomas Frinzi
President1.7yrsUS$10.22m0.046%
$ 734.8k
Patrick Williams
Chief Financial Officer4.2yrsUS$2.82m0.070%
$ 1.1m
Warren Foust
Chief Operating Officer1.4yrsUS$3.42m0.0089%
$ 140.7k
Keith Holliday
Chief Technology Officer7.5yrsUS$2.41m0.036%
$ 574.0k
Scott Barnes
Chief Medical Officer6.9yrsUS$2.48m0.064%
$ 1.0m
Brian Moore
Vice President of Investor Relations & Corporate Developmentno datano datano data
Nathaniel Sisitsky
General Counsel & Corporate Secretaryless than a yearno datano data
Nancy Sabin
Chief Marketing Officerless than a yearno datano data
James Francese
Senior Vice President of Commercial Operations - North America & APAC7.8yrsUS$2.54m0.060%
$ 957.6k
Magda Michna
Chief Clinical1.4yrsno data0.0061%
$ 97.3k
Robert Studholme
Senior Vice President of Operationsno datano data0.066%
$ 1.0m

1.7yrs

Average Tenure

60.5yo

Average Age

Experienced Management: STAA's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Thomas Frinzi
President4.3yrsUS$10.22m0.046%
$ 734.8k
Stephen Farrell
Lead Independent Director8.7yrsUS$294.87k0.031%
$ 489.4k
Aimee Weisner
Independent Director2.3yrsUS$259.96k0.031%
$ 495.7k
Lilian Zhou
Independent Directorless than a yearUS$99.69k0.0093%
$ 147.7k
Brian Williams
Member of Optometric Advisory Council15.8yrsno datano data
Arthur Crosswell Butcher
Independent Directorless than a yearno data0.0086%
$ 135.9k
Wei Jiang
Independent Directorless than a yearno data0.0072%
$ 114.5k
Elizabeth Lin
Independent Director3.7yrsUS$249.99k0.010%
$ 164.7k

3.0yrs

Average Tenure

55yo

Average Age

Experienced Board: STAA's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.